Table 1. Relative risk of fatal and non-fatal cardiovascular (CV) events associated with the use of selected CV risk management strategies, Seychelles.

Management strategy and medication	RRa
	Stroke	CEb	CV eventc
Single-risk-factor
Serum cholesterol ≥ 6.2 mmol/l
Statin	0.92	0.73	0.86
Blood pressure ≥ 140/90 mmHg
Three classes of drugs	0.67	0.76	0.70
Total CV risk	0.84	0.68	0.79
Aspirin	0.52	0.38	0.47
Polypilld

CE, coronary event; RR, relative risk.

^a See text for explanations and references underlying the RR estimates provided in this table. The RR of experiencing a CV event was calculated from the risk factor reductions obtained with the low-dose polycap. An incidence ratio of stroke to coronary events of 2:1 was assumed.¹⁸

^b Includes unstable angina and myocardial infarction.

^c Includes both stroke and coronary events.

^d Composed of aspirin, a statin, a diuretic and an angiotensin-converting enzyme inhibitor.